Azitra, Inc. Announces Preclinical Data From The Co's Platform And Pipeline On Friday, May 10, 2024, In Two Oral Sessions Entitled "Engineered Staphylococcus Epidermidis As A Protein Delivery System For Treating Skin Diseases" And "Staphylococcus Epidermidis Strain Expressing LEKTI-D6 (ATR12-351) For Netherton Syndrome"
Benzinga Newsdesk - Apr 22, 2024, 4:40PM